Rajendra Shridhar Apte

Rajendra Shridhar Apte

Auto-generated profile, based on publicly available information

Rajendra Shridhar Apte

John F. Hardesty, MD, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Cell
Verified
Journal Article
Closed access
RARajendra S. Apte
Rajendra S. Apte
DCDaniel S. Chen
Daniel S. Chen
NFNapoleone Ferrara
Napoleone Ferrara

1 September 2016 in Cell Reports
Verified
Journal Article
Open access
JMJonathan Miner
Jonathan Miner
ASAbdoulaye Sene
Abdoulaye Sene
Justin RichnerJustin Richner
Justin Richner
ASAmber M. Smith
Amber M. Smith
ASAndrea Santeford
Andrea Santeford
RARajendra S. Apte
Rajendra S. Apte
Zika virus (ZIKV) is an emerging flavivirus that causes congenital abnormalities and Guillain-Barré syndrome. ZIKV infection also results in severe eye disease characterized by optic neuritis, chorioretinal atrophy, and blindness in newborns and conjunctivitis and uveitis in adults. We evaluated ZIKV infection of the eye by using recently developed mouse models of pathogenesis. ZIKV-inoculated mice developed conjunctivitis, panuveitis, and infection of the cornea, iris, optic nerve, and ganglion and bipolar cells in the retina. This phenotype was independent of the entry receptors Axl or Mertk, given that Axl(-/-), Mertk(-/-), and Axl(-/-)Mertk(-/-) double knockout mice sustained levels of infection similar to those of control animals. We also detected abundant viral RNA in tears, suggesting that virus might be secreted from lacrimal glands or shed from the cornea. This model provides a foundation for studying ZIKV-induced ocular disease, defining mechanisms of viral persistence, and developing therapeutic approaches for viral infections of the eye.

1 April 2013 in Cell Metabolism
Verified
Journal Article
Closed access
ASAbdoulaye Sene
Abdoulaye Sene
AKAslam A. Khan
Aslam A. Khan
DCDouglas Cox
Douglas Cox
RNRei E.I. Nakamura
Rei E.I. Nakamura
ASAndrea Santeford
Andrea Santeford
RARajendra S. Apte
Rajendra S. Apte

1 November 2007 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JKJennifer Kelly
Jennifer Kelly
AKAslam Ali Khan
Aslam Ali Khan
JYJiyi Yin
Jiyi Yin
TFThomas A. Ferguson
Thomas A. Ferguson
RARajendra S. Apte
Rajendra S. Apte
Abnormal angiogenesis plays a key role in diseases of aging such as heart disease, certain cancers, and eye diseases including age-related macular degeneration. Macrophages have been shown previously to be both anti- and proangiogenic, and their role in regulating angiogenesis at sites of tissue injury is critical and complex. In this study, we analyzed cytokine gene expression patterns of mouse macrophages by real-time quantitative PCR and tested the functional effects of senescence on gene expression and macrophage polarization. Following laser injury to the retina, IL-10 was upregulated and Fas ligand (FasL), IL-12, and TNF-α were downregulated in ocular macrophages of old mice (>18 months of age). Downregulation of FasL on macrophages led to a loss of the antiangiogenic phenotype, as evidenced by the inability of these macrophages to inhibit vascular endothelial cells. Our results demonstrate that senescence, FasL, and IL-10 are key determinants of macrophage function that alter the growth of abnormal postdevelopmental blood vessels in disease processes including blinding eye disease.

15 August 2006 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
RARajendra S Apte
Rajendra S Apte
JRJennifer Richter
Jennifer Richter
JHJohn Herndon
John Herndon
TFThomas A Ferguson
Thomas A Ferguson
Age-related macular degeneration (AMD) is the leading cause of blindness in people over 50 y of age in at least three continents. Choroidal neovascularization (CNV) is the process by which abnormal blood vessels develop underneath the retina. CNV develops in 10% of patients with AMD but accounts for up to 90% of the blindness from AMD. Although the precise etiology of CNV in AMD remains unknown, the macrophage component of the inflammatory response, which has been shown to promote tumor growth and support atherosclerotic plaque formation, is thought to stimulate aberrant angiogenesis in blinding eye diseases. The current theory is that macrophage infiltration promotes the development of neovascularization in CNV. We examined the role of macrophages in a mouse model of CNV. IL-10−/− mice, which have increased inflammation in response to diverse stimuli, have significantly reduced CNV with increased macrophage infiltrates compared to wild type. Prevention of macrophage entry into the eye promoted neovascularization while direct injection of macrophages significantly inhibited CNV. Inhibition by macrophages was mediated by the TNF family death molecule Fas ligand (CD95-ligand). Immune vascular interactions can be highly complex. Normal macrophage function is critical in controlling pathologic neovascularization in the eye. IL-10 regulates macrophage activity in the eye and is an attractive therapeutic target in order to suppress or inhibit CNV in AMD that can otherwise lead to blindness.

11 August 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
RNRei Nakamura
Rei Nakamura
ASAbdoulaye Sene
Abdoulaye Sene
ASAndrea Santeford
Andrea Santeford
AGAbdelaziz Gdoura
Abdelaziz Gdoura
SKShunsuke Kubota
Shunsuke Kubota
RARajendra S. Apte
Rajendra S. Apte
Macrophage dysfunction plays a pivotal role during neovascular proliferation in diseases of ageing including cancers, atherosclerosis and blinding eye disease. In the eye, choroidal neovascularization (CNV) causes blindness in patients with age-related macular degeneration (AMD). Here we report that increased IL10, not IL4 or IL13, in senescent eyes activates STAT3 signalling that induces the alternative activation of macrophages and vascular proliferation. Targeted inhibition of both IL10 receptor-mediated signalling and STAT3 activation in macrophages reverses the ageing phenotype. In addition, adoptive transfer of STAT3-deficient macrophages into eyes of old mice significantly reduces the amount of CNV. Systemic and CD163+ eye macrophages obtained from AMD patients also demonstrate STAT3 activation. Our studies demonstrate that impaired SOCS3 feedback leads to permissive IL10/STAT3 signalling that promotes alternative macrophage activation and pathological neovascularization. These findings have significant implications for our understanding of the pathobiology of age-associated diseases and may guide targeted immunotherapy.